Scientific Programme

Thursday, 17 June 2021

Joint Sessions, Virtual Room 1 08:30 - 09:30 Joint SSP-EFP Session COVID-19

Chair: Michael Tamm (Basel, Switzerland) Chair: Zouhair Souissi (Tunis, Tunisia)

08:30 - 08:40 Short 2021 update on treatment options in COVID19 Alexandra Calmy (Geneva, Switzerland)

08:40 - 08:50 COVID in children: (including multisystem inflammatory syndrome) Arnaud L’Huillier (Geneva, Switzerland)

08:50 - 09:00 Acute respiratory failure in COVID patients outside the ICU Dan Adler (Geneva, Switzerland)

09:00 - 09:10 COVID and vascular disease (vasculitis, thromboembolic disorders..) Marc Righini (Geneva, Switzerland)

09:10 - 09:20 Swiss COVID lung study Manuela Funke-Chambour (Bern, Switzerland)

09:20 - 09:30 Q & A

Joint Sessions, Virtual Room 2 08:30 - 09:30 Joint SSP-EFP Session Sleep disordered breathing 1

Chair: Robert Thurnheer (Münsterlingen, Switzerland) Chair: Quy Ngo Chau (Hanoi, Viet Nam)

08:30 - 08:50 New Swiss recommendations 2020 for the diagnosis and treatment of sleep apnoea Raphaël Heinzer (Lausanne, Switzerland)

08:50 - 09:05 Residual sleepiness in patients treated for sleep apnoea Jean-Louis Pepin (Grenoble, France)

09:05 - 09:20 New treatments for OSA Malcolm Kohler (Zürich, Switzerland)

09:20 - 09:30 Q & A

Joint Sessions, Virtual Room 3 08:30 - 09:30 Joint SSP-EFP Session E-cigarettes

Chair: Macé Schuurmans (Winterthur, Switzerland) Chair: Florin Mihaltan (Bucharest, Romania)

Page 1 / 18 Scientific Programme

08:30 - 08:45 Toxicity of E-Cigarettes Philippe Camus (Dijon, France)

08:45 - 09:00 E-cigarettes and „Heat not burn devices“: an individual opportunity, but risks for society Jacques Cornuz (Lausanne, Switzerland)

09:00 - 09:15 Impact of e-cigarettes on smoking in adolescents Jürg Barben (St. Gallen, Switzerland)

09:15 - 09:25 Q & A

Joint Sessions, Virtual Room 1 09:45 - 10:45 Joint SSP-EFP Session ILD 2: Sarcoidosis

Chair: Thomas Geiser (Bern, Switzerland) Chair: Jean-Marc Fellrath (Neuchâtel, Switzerland)

09:45 - 10:00 Sarcoidosis (in Switzerland): What’s new? Martin Brutsche (St. Gallen, Switzerland)

10:00 - 10:15 Pulmonary sarcoidosis - new treatment options Geneviève Dion (Quebec, Canada)

10:15 - 10:30 Cardiac sarcoidosis - diagnosis and treatment Jean-Marc Naccache (Paris, France)

10:30 - 10:40 Q & A

Joint Sessions, Virtual Room 2 09:45 - 10:45 Joint SSP-EFP Session Sleep disordered breathing 2

Chair: Jean-Louis Pepin (Grenoble, France) Chair: Daniel Trachsel (Basel, Switzerland)

09:45 - 10:00 Drug induced sleep endoscopy" (DISE): for whom and why? Nicolas Dulguerov (Geneva, Switzerland)

10:00 - 10:15 Insomnia and OSA Sandrine Launois (Paris, France)

10:15 - 10:30 Specific aspects of obstructive sleep apnea in children Claudine Gysin (Zürich, Switzerland)

10:30 - 10:40 Q & A

Page 2 / 18 Scientific Programme

Joint Sessions, Virtual Room 3 09:45 - 10:45 Joint SSP/EFP Session Pulmonary rehabilitation

Chair: Thomas Sigrist (Barmelweid, Switzerland) Chair: Christophe Uldry (Lausanne, Switzerland) Chair: Mohammed El Ibrahimi (Casablance, Morocco)

09:45 - 10:00 Benefits of rehabilitation in comparison to inhalation therapy Bernard Egger (Rolle, Switzerland)

10:00 - 10:15 Combination of in- and outpatient rehabilitation programs Jean Bourbeau (Montreal, Canada)

10:15 - 10:30 Obstacles for respiratory rehabilitation programmes: how to move forward? Swantje Beyer (Winterthur, Switzerland)

10:30 - 10:40 Q & A

Joint Sessions, Virtual Room 1 11:00 - 12:00 Joint ERS-SSP/EFP Session Interstitial lung diseases 1

Chair: Laurent Nicod (Lausanne, Switzerland) Chair: Moulay Hicham Afif (Casablanca, Morocco)

11:00 - 11:15 Hypersensitivity Pneumonitis - Diagnosis and treatment Moulay Hicham Afif (Casablanca, Morocco)

11:15 - 11:30 New antifibrotic drugs Katrin Hostettler (Basel, Switzerland)

11:30 - 11:45 Secrets of radiological ILD diagnosis and use of AI Lukas Ebner (Bern, Switzerland)

11:45 - 11:55 Q & A

Joint Sessions, Virtual Room 2 11:00 - 12:00 Joint SSP-EFP Session Sleep disordered breathing 3

Chair: Tsogyal Daniela Latshang (Chur, Switzerland) Chair: Lamia Chergui-Hafi (Paris, France) Chair: Sarin Chan (Phnom Penh, Cambodia)

11:00 - 11:15 Sleep apnoea and cardiovascular risk factors: where are we? New biomarkers? Esther Irene Schwarz (Zürich, Switzerland)

11:15 - 11:30 SOMNEF study: Sleep patterns and major sleep complaints: a global perspective Franck Soyez (Antony, France)

Page 3 / 18 Scientific Programme

11:30 - 11:45 Emerging countries: prevalence and impact of sleep apnoea in sub- Saharan Africa: BeSAS study Prudence Wachinou (Cotonou, Benin)

11:45 - 11:55 Q & A

Joint Sessions, Virtual Room 3 11:00 - 12:00 Joint SSP/EFP Session The lung and the environment

Chair: Alice Zürcher (Zürich, Switzerland) Chair: Jean-Marie Schnyder (Crans-Montana, Switzerland)

11:00 - 11:15 Ambient air pollution and the COVID pandemic - what is the link? Nino Künzli (Basel, Switzerland)

11:15 - 11:30 COPD and domestic pollution Chantal Raherison (Bordeaux, France)

11:30 - 11:45 The lung and climate changes Agnès Hamzaoui (Tunis, Tunisia)

11:45 - 11:55 Q & A

Industry Sessions, Virtual Room 1 12:15 - 13:00 Satellite Lunch Symposium OM Pharma Suisse Particle size matters - do not stop halfway

Chair: Christophe von Garnier (Lausanne, Switzerland)

12:15 - 12:25 Unmet needs in asthma and COPD Christophe von Garnier (Lausanne, Switzerland)

12:25 - 12:50 Why is it so important to treat the whole lung Brian Lipworth (United Kingdom)

12:50 - 13:00 Q & A

Industry Sessions, Virtual Room 2 12:15 - 13:00 Satellite Lunch Symposium Sanofi Dupilumab (Dupixent) in severe asthma: A new path...

12:15 - 12:30 … for patients uncontrolled under ICS/LABA Laurent Nicod (Lausanne, Switzerland)

12:30 - 12:40 … for OCS-dependent patients Tsogyal Daniela Latshang (Chur, Switzerland)

Page 4 / 18 Scientific Programme

12:40 - 12:50 … in the real world C. Taillé (Paris, France)

12:50 - 13:00 Panel discussion: what can Dupixent offer to severe asthma patients? C. Taillé (Paris, France) Tsogyal Daniela Latshang (Chur, Switzerland) Laurent Nicod (Lausanne, Switzerland)

Industry Sessions, Virtual Room 3 12:15 - 13:00 Satellite Lunch Symposium Vertex Transforming Care in Cystic Fibrosis: The Past, The Present and The Future

Chair: Alain Sauty (Lausanne, Switzerland)

12:15 - 12:25 Introduction to the Past of Cystic Fibrosis Alain Sauty (Lausanne, Switzerland)

12:25 - 12:35 Experience from the present in adult care: Successes and new challenges Jérôme Plojoux (Geneva, Switzerland)

12:35 - 12:45 Experience from the present in pediatrics and outlook to the future Alexander Möller (Zürich, Switzerland)

12:45 - 13:00 Discussion and close Alain Sauty (Lausanne, Switzerland)

Joint Sessions, Virtual Room 1 13:15 - 14:15 Joint ERS-SSP/EFP Session Secondary interstitial lung diseases

Chair: Paola Gasche-Soccal (Geneva, Switzerland) Chair: Manuela Funke-Chambour (Bern, Switzerland)

13:15 - 13:30 Pulmonary manifestations of graft vs host disease after stem cell transplantation Anne Bergeron (Paris, France)

13:30 - 13:45 Pulmonary diseases related to immunotherapies Jérôme Plojoux (Geneva, Switzerland)

13:45 - 14:00 Non infectious disorders after lung transplantation Christian Benden (Zurich, Switzerland)

14:00 - 14:10 Q & A

Page 5 / 18 Scientific Programme

Joint Sessions, Virtual Room 2 13:15 - 14:15 Joint SSP-EFP Session Severe Asthma

Chair: Thomas Rothe (Davos, Switzerland) Chair: Zeina Aoun (Beirut, Lebanon)

13:15 - 13:30 Burden of systemic corticosteroid therapy in asthma Louis-Philippe Boulet (Quebec, Canada)

13:30 - 13:45 Presentation of the Swiss Severe Asthma Registry Jörg Leuppi (Liestal, Switzerland)

13:45 - 14:00 Update on biological treatments? Roland Buhl (Mainz, Germany)

14:00 - 14:10 Q & A

Industry Sessions, Virtual Room 3 13:15 - 14:15 Satellite Atelier MSD Merck Sharp & Dohme AG New treatment options in pulmonary arterial hypertension

MSD Merck Sharp & Dohme AG New treatment options in pulmonary arterial hypertension

13:15 - 13:35 New Treatment options in Pulmonary Arterial Hypertension Frédéric Lador (Geneva, Switzerland)

13:35 - 13:55 Update treatment strategies and algorithms in Pulmonary Arterial Hypertension Ekkehard Grünig (Heidelberg, Germany)

13:55 - 14:15 Critical Pulmonary Arterial Hypertension Patient cases - 2 cases to be discussed Ekkehard Grünig (Heidelberg, Germany)

Joint Sessions, Virtual Room 1 14:30 - 15:30 Joint Session SSP-EFP Thrombo-embolic disease

Chair: Andrea Azzola (Lugano, Switzerland) Chair: Laurent Bertoletti (St Etienne, France)

14:30 - 15:00 Post PE management Laurent Bertoletti (St Etienne, France)

15:00 - 15:20 Balloon pulmonary angioplasty (BPA) for CTEPH Frédéric Lador (Geneva, Switzerland)

15:20 - 15:30 Q & A

Page 6 / 18 Scientific Programme

Joint Sessions, Virtual Room 2 14:30 - 15:30 Joint Session SSP-EFP Pulmonary function testing

Chair: Jean Frederic Vodoz (Montreux, Switzerland) Chair: Rondro Raharimanana (Antananarivo, Madagascar)

14:30 - 14:45 Impact of the new prediction equations (GLI) on patient classification Part 1: Spirometry Konrad Bloch (Zürich, Switzerland)

14:45 - 15:00 Impact of the new prediction equations (GLI) on patient classification Part 2: Pulmonary volumes and DLCO Bruno Degano (Grenoble, France)

15:00 - 15:15 Challenges of implementing spirometry in emerging countries Andre Amaral (London, United Kingdom)

15:15 - 15:25 Q & A

Industry Sessions, Virtual Room 3 14:30 - 15:15 Satellite Symposium Astra Zeneca From avoiding the use of oral corticosteroids to a potential new master switch in severe asthma

Astra Zeneca

14:30 - 14:50 Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE trial Daiana Stolz (Basel, Switzerland)

14:50 - 15:15 Efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma: NAVIGATOR trial Andrew Menzies-Gow (London, United Kingdom)

Meet the expert session (separate on Zoom) - https://astrazeneca.zoom.u s/j/98071393219?pwd=M3BZL2JvU0haQytLZTlOd3lCZlIyQT09 Daiana Stolz (Basel, Switzerland) Andrew Menzies-Gow (London, United Kingdom)

Joint Sessions, Virtual Room 1 15:45 - 16:45 Joint SSP-EFP Session Pulmonary Arterial Hypertension

Chair: John-David Aubert (Lausanne, Switzerland) Chair: Markus Schwerzmann (Bern, Switzerland) Chair: Dominique Butenda (Belgium)

15:45 - 16:00 Assessment of cardiac output: where is the truth? Léon Genecand (Geneva, Switzerland)

16:00 - 16:15 Haemodynamic definition of PH and exercise right heart catheterization Silvia Ulrich (Zürich, Switzerland)

Page 7 / 18 Scientific Programme

16:15 - 16:30 New treatments and treatment strategy in PAH Marc Humbert (Paris, France)

16:30 - 16:40 Q & A

Joint Sessions, Virtual Room 2 15:45 - 16:45 Joint Session SSP-EFP Pulmonary function test challenge

Chair: Anh-Tuan Dinh-Xuan (Paris, France) Chair: Pierre-Olivier Bridevaux (Sion, Switzerland)

15:45 - 16:10 Adult case presentations Anh-Tuan Dinh-Xuan (Paris, France) Pierre-Olivier Bridevaux (Sion, Switzerland)

16:10 - 16:35 Pediatric case presentations Sylvain Blanchon (Lausanne, Switzerland)

16:35 - 16:45 Q & A

Industry Sessions, Virtual Room 3 15:45 - 16:30 Satelite Symposia GSK The journey of inhaled corticosteroids in COPD - what we know today

Do not forget to visit our Medical Booth for further scientific discussions! Trade marks are owned by or licensed to the GSK group of companies. ©2021 GSK group of companies or its licensor. Talstrasse 3-5, 3053 Münchenbuchsee. PM-CH-MPL- AGND-210003-05/2021

Chair: Matthias Herrmann (Basel, Switzerland)

15:45 - 15:50 Introduction into the topic and speakers Chair Matthias Herrmann (Basel, Switzerland)

15:50 - 16:05 Overtreatment and undertreatment in COPD Carolin Steinack (Zürich, Switzerland)

16:05 - 16:20 ICS Withdrawal in COPD Matthias Herrmann (Basel, Switzerland)

16:20 - 16:30 Q&A Matthias Herrmann (Basel, Switzerland)

Page 8 / 18 Scientific Programme

Joint Sessions, Virtual Room 1 17:00 - 17:15 Daily synopsis & Congress closing day 1 (English)

Chair: Georgia Mitropoulou (Lausanne, Switzerland) Chair: Jean-Paul Janssens (Geneva, Switzerland) Chair: Manon Kolb (Geneva, Switzerland) Chair: Raphaël Heinzer (Lausanne, Switzerland)

Joint Sessions, Virtual Room 2 17:00 - 17:25 Daily synopsis & Congress closing day 1 (French)

17:00 - 17:05 Summary of the Day - Virtual Room 1 Bouchra Lamia (France)

17:05 - 17:10 Summary of the Day - Virtual Room 2 Céline Baaklini (France)

17:10 - 17:15 Summary of the Day - Virtual Room 3 Ahmad Ben Saad (France)

17:15 - 17:25 Joint summary and closing words - Day 1 Bouchra Lamia (France) Céline Baaklini (France) Ahmad Ben Saad (France)

Industry Sessions, Virtual Room 3 17:15 - 18:00 Satellite Atelier OM Pharma Suisse Workshop “Assessing small airways (dys)function”

OM Pharma Suisse

17:15 - 18:00 Workshop “Assessing small airways (dys)function” Brian Lipworth (United Kingdom)

Joint Sessions, Virtual Room 2 17:30 - 18:30 Joint SSP-EFP Session Round table on collaboration and research within the EFP

Chair: Chantal Raherison (Bordeaux, France)

17:30 - 17:38 La recherche extra-hexagonale avant l’EFP : retour d’expérience Charles Mayaud (Paris, France) Pierre L'Her (Clamart, France)

17:38 - 17:46 Pourquoi l’EFP ? Pourquoi la recherche dans l’EFP ? Ali Ben Kheder (Tunis, Tunisia)

Page 9 / 18 Scientific Programme

17:46 - 17:54 Etat des lieux de la recherche dans l'EFP Franck Soyez (Antony, France) Bernard Pigerias (Nice, France)

17:54 - 18:02 Statut des stagiaires associés en France Didier Debieuvre (Mulhouse, France)

18:02 - 18:10 Rôle du conseil scientifique de l’EFP Georges Khayat (Beirut, Lebanon)

18:10 - 18:18 L'EFP vu par la SPLF Antoine Magnan (Suresnes, France)

18:18 - 18:26 Remise des bourses EFP 2021 Georges Khayat (Beirut, Lebanon)

Assemblies, Virtual Room 1 18:00 - 19:00 General Assembly SSPH

Page 10 / 18 Scientific Programme

Friday, 18 June 2021

Joint Sessions, Virtual Room 1 08:45 - 09:45 Joint Session SSP-EFP Functional respiratory disorders

Chair: Florian Charbonnier (Geneva, Switzerland) Chair: Grégoire Gex (Sion, Switzerland)

08:45 - 09:00 Dysfunctional breathing, hyperventilation Syndrome (including COVID- related) Stephen Fowler (Manchester, United Kingdom)

09:00 - 09:15 Inducible laryngeal obstruction (ILO) Jörg Edgar Bohlender (Zürich, Switzerland)

09:15 - 09:30 Dysfunctional breathing under NIV Marjolaine Georges (Dijon, France)

09:30 - 09:40 Q & A

Joint Sessions, Virtual Room 2 08:45 - 09:45 Joint Session SSP-EFP Lung cancer: special surgical situations

Chair: Joanna Domagala-Kulawik (Warsaw, Poland) Chair: Didier Lardinois (Basel, Switzerland)

08:45 - 09:00 Surgical management of pulmonary metastases Michel Gonzalez (Lausanne, Switzerland)

09:00 - 09:15 How to manage post-segmentectomy N2 disease ? Gregor Kocher (Bern, Switzerland)

09:15 - 09:30 Expanding surgery for oligometastatic stage IV lung cancer Mark Wiese (Basel, Switzerland)

09:30 - 09:40 Q & A

Joint Sessions, Virtual Room 3 08:45 - 09:45 Joint Session SSP-EFP Mycobacteria 2

Chair: Alexander Turk (Horgen, Switzerland) Chair: Jean-Paul Janssens (Geneva, Switzerland)

08:45 - 09:00 Latent tuberculosis – newly defined? How to diagnose? How to treat? Otto Schoch (St. Gallen, Switzerland)

Page 11 / 18 Scientific Programme

09:00 - 09:15 Non tuberculous mycobacteria: the new kid on the block? Nicolas Veziris (Paris, France)

09:15 - 09:30 Non tuberculous mycobacteria and HIV Olivier Nawej Tshikung (Geneva, Switzerland)

09:30 - 09:40 Q & A

Joint Sessions, Virtual Room 1 10:00 - 11:00 Joint Session SSP-EFP Respiratory disorders at extremes of life

Chair: Raphaël Heinzer (Lausanne, Switzerland) Chair: Jean-Paul Janssens (Geneva, Switzerland)

10:00 - 10:15 Sleep disorders in infants and toddlers Daniel Trachsel (Basel, Switzerland)

10:17 - 10:32 NIV and CPAP in patients over 75: is it possible? Chloé Cantero (Geneva, Switzerland)

10:34 - 10:49 Periodical breathing and heart failure: where are we today? Jean-Paul Janssens (Geneva, Switzerland)

10:50 - 11:00 Q & A

Joint Sessions, Virtual Room 2 10:00 - 11:00 Joint Session SSP-EFP Treatment of benign stenosis of proximal intrathoracic airways

Chair: Peter Kestenholz (Luzern, Switzerland) Chair: Alban Lovis (Lausanne, Switzerland)

10:00 - 10:15 Endoscopic management of benign proximal airway stenosis Hervé Dutau (Marseille, France)

10:15 - 10:30 Surgical management of benign proximal airway stenosis Emmanuel Martinod (Paris, France)

10:30 - 10:45 Is the 3D printed stent the stent we all dream of? Daniel Franzen (Zürich, Switzerland)

10:45 - 10:55 Q & A

Page 12 / 18 Scientific Programme

Joint Sessions, Virtual Room 3 10:00 - 11:00 Joint SSP-EFP Session Mycobacteria 1

Chair: Sebastian Ott (Berne, Switzerland) Chair: Jesica Mazza-Stalder (Lausanne, Switzerland)

10:00 - 10:15 Tuberculosis locally and globally in 2021 Gunar Günther (Bern, Switzerland)

10:15 - 10:30 Tuberculosis «goes molecular» – state of the art in the diagnosis of active disease and resistance Peter Keller (Bern, Switzerland)

10:30 - 10:45 Monitoring drug levels in TB treatment Jan Fehr (Zurich, Switzerland)

10:45 - 10:55 Q & A

Joint Sessions, Virtual Room 1 11:15 - 12:15 Joint SSP/EFP Session Non-invasive ventilation

Chair: Jochen Rüdiger (Basel, Switzerland) Chair: Maura Prella (Lausanne, Switzerland)

11:15 - 11:30 Swiss 2020 NIV guidelines Jean-Paul Janssens (Geneva, Switzerland)

11:30 - 11:45 NIV: Trouble shooting Esther Irene Schwarz (Zürich, Switzerland)

11:45 - 12:00 High-Flow versus NIV in chronic respiratory failure Grégoire Gex (Sion, Switzerland)

12:00 - 12:10 Q & A

Joint Sessions, Virtual Room 2 11:15 - 12:15 Joint SSP-EFP Session Lung Cancer

Chair: Frédéric Triponez (Geneva, Switzerland) Chair: Radha Paratian (Réunion, Mauritius)

11:15 - 11:30 Update on evidences for lung cancer screening Christophe von Garnier (Lausanne, Switzerland)

11:30 - 11:45 Lung cancer screening in Switzerland – where are we? Milo Puhan (Zürich, Switzerland)

11:45 - 12:00 Targeted treatment in lung cancer Christos Chouaid (Paris, France)

12:00 - 12:10 Q & A

Page 13 / 18 Scientific Programme

Joint Sessions, Virtual Room 3 11:15 - 12:15 Joint SSP-EFP Session Vaccination in SARS-CoV-2 infection

Chair: Paola Gasche-Soccal (Geneva, Switzerland)

11:15 - 11:30 COVID-19 Vaccination Christiane Eberhardt (Geneva, Switzerland)

11:30 - 11:40 Q & A

Industry Sessions, Virtual Room 1 12:30 - 13:15 Satellite Symposium Novartis Satisfying unmet medical needs in asthma care and beyond

Novartis

Chair: Daiana Stolz (Basel, Switzerland)

12:30 - 12:35 Welcome & Introduction Daiana Stolz (Basel, Switzerland)

12:35 - 12:50 Latest evidence for LAMA in asthma Pierre-Olivier Bridevaux (Sion, Switzerland)

12:50 - 13:05 New treatment options for nasal polyp patients Peter Jandus (Genève, Switzerland)

13:05 - 13:15 Live Q&A with speakers Daiana Stolz (Basel, Switzerland)

Paediatric Pulmology Sessions, Virtual Room 1 13:30 - 14:30 Pediatric session Respiratory failure in pediatric patients

Chair: Christian Bieli (London, United Kingdom) Chair: Jürg Hammer (Basel, Switzerland)

13:30 - 13:45 Use of high flow humidified oxygen therapy in children Jürg Hammer (Basel, Switzerland)

13:45 - 14:00 Pre and peri operative preparation to NIV for high risk children before major surgery Regula Corbelli (Geneva, Switzerland)

14:00 - 14:15 Long term NIV in children Miriam Giarrana (Zürich, Switzerland)

14:15 - 14:25 Q & A

Page 14 / 18 Scientific Programme

Joint Sessions, Virtual Room 2 13:30 - 14:30 Joint SSP-EFP Session Pneumoquiz Blickdiagnosen

Chair: Martin Brutsche (St. Gallen, Switzerland) Chair: Thomas Kluckert (St. Gallen, Switzerland) Chair: Michael Tamm (Basel, Switzerland) Chair: Spasenija Savic Prince (Basel, Switzerland)

13:30 - 14:15 Pneumoquiz Blickdiagnosen Michael Tamm (Basel, Switzerland) Martin Brutsche (St. Gallen, Switzerland) Thomas Kluckert (St. Gallen, Switzerland) Spasenija Savic Prince (Basel, Switzerland)

14:15 - 14:30 Award Ceremony: Swiss Lung Association Best publication by a young researcher Otto Schoch (St. Gallen, Switzerland) Maurice Roeder (Zurich, Switzerland) Lu Tan (Zurich, Switzerland)

Industry Sessions, Virtual Room 3 13:30 - 14:30 Satellite Atelier Boehringer Ingelheim - Combined Pulmonary Fibrosis and Emphysema: profiling at its best - CPFE: a phenotype between known lung diseases-

Chair: Christophe von Garnier (Lausanne, Switzerland)

13:30 - 13:35 Introduction Christophe von Garnier (Lausanne, Switzerland)

13:35 - 13:55 What to know and what to do? Vincent Cottin (Lyon, France)

13:55 - 14:00 Discussion

14:00 - 14:15 Radiological work-up Lukas Ebner (Bern, Switzerland)

14:15 - 14:25 Discussion

14:25 - 14:30 Closing Christophe von Garnier (Lausanne, Switzerland)

Paediatric Pulmology Sessions, Virtual Room 1 14:45 - 15:45 Pediatric Grand Rounds

Chair: Isabelle Rochat (Lausanne, Switzerland) Chair: Nicolas Regamey (Luzern, Switzerland)

Page 15 / 18 Scientific Programme

14:45 - 14:57 Recurrent pneumonia in a 15 year-old patient: what could be the underlying cause? Alena Kuhn (Aarau, Switzerland)

14:57 - 15:09 Severe congenital chlythorax in a term-born infant Carolyn Luhmann (Luzern, Switzerland)

15:09 - 15:21 Why is the fungus in the lung? Anja Jochmann (Basel, Switzerland)

15:21 - 15:33 2 year-old girl with tachypnea and failure to thrive Marina Bullo (Bern, Switzerland)

15:33 - 15:43 Q & A

Joint Sessions, Virtual Room 2 14:45 - 15:45 Joint Session SSP-EFP Pleural disease

Chair: Marc de Perrot (Toronto, Canada) Chair: Michel Gonzalez (Lausanne, Switzerland)

14:45 - 15:00 Pleural fibrinolysis update of literature and practices Benoit Bédat (Geneva, Switzerland)

15:00 - 15:15 New guidelines for the management of mesothelioma Marc de Perrot (Toronto, Canada)

15:15 - 15:30 Molecular diagnostic in the management of respiratory infections – any news? Daiana Stolz (Basel, Switzerland)

15:30 - 15:40 Q & A

Industry Sessions, Virtual Room 3 14:45 - 15:30 Satelite Symposia GSK Which Target to treat first? Biomarkers and Comorbidities in Severe Asthma

Trade marks are owned by or licensed to the GSK group of companies. ©2021 GSK group of companies or its licensor. Talstrasse 3-5, 3053 Münchenbuchsee. PM-CH- MPL-AGND-210003-05/2021

Chair: Miriam Marchon (Berne, Switzerland)

14:45 - 14:50 Introduction to the topic and speakers Chair Miriam Marchon (Berne, Switzerland)

14:50 - 15:05 The importance of Biomarkers & Phenotyping in Severe Asthma Miriam Marchon (Berne, Switzerland)

Page 16 / 18 Scientific Programme

15:05 - 15:20 Severe Asthma - Comorbidities & Real Life Data PD. Marc Spielmanns (Zurich, Switzerland)

15:20 - 15:30 Q&A Miriam Marchon (Berne, Switzerland)

Paediatric Pulmology Sessions, Virtual Room 1 16:00 - 17:00 Pediatric Session Pulmonary disease from childhood to adult life

Chair: Constance Barazzone-Argiroffo (Geneva, Switzerland) Chair: Nicolas Regamey (Luzern, Switzerland)

16:00 - 16:15 Early origin of pulmonary disease Sejal Saglani (London, United Kingdom)

16:15 - 16:30 New treatment options in cystic fibrosis Alexander Möller (Zürich, Switzerland)

16:30 - 16:45 Asthma from childhood to adult life Francine Ducharme (Montreal, Canada)

16:45 - 16:55 Q & A

Session, Virtual Room 2 16:00 - 17:00 Swiss Lung Association: Supported research projects

Chair: Jörg Spieldenner (Bern, Switzerland) Chair: Otto Schoch (St. Gallen, Switzerland) Chair: John-David Aubert (Lausanne, Switzerland)

16:00 - 16:10 Introduction Jörg Spieldenner (Bern, Switzerland) Otto Schoch (St. Gallen, Switzerland) John-David Aubert (Lausanne, Switzerland)

16:10 - 16:16 Role of alternative RNA splicing in the regulation of antiviral responses of the respiratory epithelium Marco Alves (Bern, Switzerland)

16:16 - 16:22 Predicting asthma attacks in Swiss children: SPAC-Attacks, a clinical cohort study Cristina Ardura Garcia (Bern, Switzerland)

16:22 - 16:28 CT-based radiomics texture signature for the prediction of drug response to nintedanib in experimental lung fibrosis Britta Maurer (Bern, Switzerland)

16:28 - 16:34 Cell and gene therapy for treatment of AAT deficiency Tiziana Cremona (Bern, Switzerland)

Page 17 / 18 Scientific Programme

16:34 - 16:40 Tailored intervention on nutrition and exercise for obstructive sleep apnea patients treated with CPAP: TINE STUDY Mathieu Berger (Lausanne, Switzerland)

16:40 - 16:46 Establishing a Swiss National Lung Cancer Screening Program Christophe von Garnier (Lausanne, Switzerland)

16:46 - 16:56 Q & A

Joint Sessions, Virtual Room 1 17:00 - 17:25 JOINT Daily synopsis & Congress closing / farewell (French)

17:00 - 17:05 Summary of the Day - Virtual Room 1 Sven Gunther (France)

17:05 - 17:10 Summary of the Day - Virtual Room 2 Carine Harmouche (France)

17:10 - 17:15 Summary of the Day - Virtual Room 3 Ines Zendah (France)

17:15 - 17:25 Joint summary and closing words - Day 2 Sven Gunther (France) Carine Harmouche (France) Ines Zendah (France)

Joint Sessions, Virtual Room 2 17:00 - 17:25 JOINT Daily synopsis & Congress closing / farewell (English)

Chair: Jean-Paul Janssens (Geneva, Switzerland) Chair: Georgia Mitropoulou (Lausanne, Switzerland) Chair: Manon Kolb (Geneva, Switzerland) Chair: Isabelle Ruchonnet-Metrailler (Geneva, Switzerland)

Page 18 / 18

Powered by TCPDF (www.tcpdf.org)